APPLICATIONS PUBLISHED 3 APRIL 2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Warner-Lambert 1192144*
Bristol-Myers Squibb 1192145*
AstraZeneca 1192146*
The United States Government as represented by the Department of Health and Human Services 1192147*
AstraZeneca 1192148*
Ortho-McNeil Pharmaceutical 1192149*
AstraZeneca 1192150*
Glaxo Group 1192151*
Pierre Fabre Medicament 1192152*
Bayer 1192153*
AstraZeneca 1192154*
University of Virginia Patent Foundation; National Institutes of Health 1192159*
Neurogen 1192160*
Purdue Research Foundation; University of North Carolina 1192161*
Indena 1192162*
Ortho-McNeill Pharmaceuticals 1192163*
Vernalis Research 1192164*
Bristol-Myers Squibb 1192165*
Mallinckrodt 1192166*
Her Majesty the Queen in right of Canada, as represented by The Minister of Agriculture and Agri-Food Canada 1192167*
Human Genome Sciences; Lajolla Institute for Allergy and Immunology 1192168*
CV Therapeutics 1192169*
CV Therapeutics 1192170*
Eli Lilly 1192178*
King's College London 1192180*